世界の高性能医薬品有効成分(HPAPI)市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV01193)
◆英語タイトル:Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Insights and Forecast to 2026
◆商品コード:QYR20NV01193
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは高性能医薬品有効成分(HPAPI)の世界市場について調査・分析した資料です。種類別(合成成分、生物成分、その他)の市場規模、用途別(腫瘍学、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別高性能医薬品有効成分(HPAPI)の競争状況、市場シェア
・世界の高性能医薬品有効成分(HPAPI)市場:種類別市場規模 2015年-2020年(合成成分、生物成分、その他)
・世界の高性能医薬品有効成分(HPAPI)市場:種類別市場規模予測 2021年-2026年(合成成分、生物成分、その他)
・世界の高性能医薬品有効成分(HPAPI)市場:用途別市場規模 2015年-2020年(腫瘍学、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他)
・世界の高性能医薬品有効成分(HPAPI)市場:用途別市場規模予測 2021年-2026年(腫瘍学、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他)
・北米の高性能医薬品有効成分(HPAPI)市場分析:米国、カナダ
・ヨーロッパの高性能医薬品有効成分(HPAPI)市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの高性能医薬品有効成分(HPAPI)市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の高性能医薬品有効成分(HPAPI)市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの高性能医薬品有効成分(HPAPI)市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Bristol-Myers Squibb、Novartis、Sanofi Aventis、Pfizer、Lonza、Novasep、Hospira、BASF、Merck、Bayer、Teva Pharmaceuticals、Boehringer Ingelheim
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market
The global High Performance Active Pharmaceutical Ingredients (HPAPI) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global High Performance Active Pharmaceutical Ingredients (HPAPI) Scope and Market Size
High Performance Active Pharmaceutical Ingredients (HPAPI) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global High Performance Active Pharmaceutical Ingredients (HPAPI) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the High Performance Active Pharmaceutical Ingredients (HPAPI) market is segmented into
Synthetic Ingredients
Biological Ingredients
Others

Segment by Application, the High Performance Active Pharmaceutical Ingredients (HPAPI) market is segmented into
Oncology
Glaucoma
Anti-diabetic
Cardiovascular
Musculoskeletal
Hormonal
Others

Regional and Country-level Analysis
The High Performance Active Pharmaceutical Ingredients (HPAPI) market is analysed and market size information is provided by regions (countries).
The key regions covered in the High Performance Active Pharmaceutical Ingredients (HPAPI) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and High Performance Active Pharmaceutical Ingredients (HPAPI) Market Share Analysis
High Performance Active Pharmaceutical Ingredients (HPAPI) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in High Performance Active Pharmaceutical Ingredients (HPAPI) business, the date to enter into the High Performance Active Pharmaceutical Ingredients (HPAPI) market, High Performance Active Pharmaceutical Ingredients (HPAPI) product introduction, recent developments, etc.

The major vendors covered:
Bristol-Myers Squibb
Novartis
Sanofi Aventis
Pfizer
Lonza
Novasep
Hospira
BASF
Merck
Bayer
Teva Pharmaceuticals
Boehringer Ingelheim

【レポートの目次】

1 Study Coverage
1.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Introduction
1.2 Market Segments
1.3 Key High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Growth Rate by Type
1.4.2 Synthetic Ingredients
1.4.3 Biological Ingredients
1.4.4 Others
1.5 Market by Application
1.5.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Glaucoma
1.5.4 Anti-diabetic
1.5.5 Cardiovascular
1.5.6 Musculoskeletal
1.5.7 Hormonal
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size, Estimates and Forecasts
2.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue 2015-2026
2.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales 2015-2026
2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Competitor Landscape by Players
3.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Manufacturers
3.1.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Manufacturers (2015-2020)
3.1.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Manufacturers (2015-2020)
3.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Manufacturers
3.2.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Manufacturers (2015-2020)
3.2.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue in 2019
3.2.5 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Price by Manufacturers
3.4 High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base Distribution, Product Types
3.4.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers High Performance Active Pharmaceutical Ingredients (HPAPI) Product Type
3.4.3 Date of International Manufacturers Enter into High Performance Active Pharmaceutical Ingredients (HPAPI) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020)
4.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type (2015-2020)
4.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Type (2015-2020)
4.1.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast by Type (2021-2026)
4.2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast by Type (2021-2026)
4.2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast by Type (2021-2026)
4.2.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020)
5.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application (2015-2020)
5.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Application (2015-2020)
5.1.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Price by Application (2015-2020)
5.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast by Application (2021-2026)
5.2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast by Application (2021-2026)
5.2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast by Application (2021-2026)
5.2.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Price Forecast by Application (2021-2026)

6 North America
6.1 North America High Performance Active Pharmaceutical Ingredients (HPAPI) by Country
6.1.1 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country
6.1.2 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Market Facts & Figures by Type
6.3 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Market Facts & Figures by Application

7 Europe
7.1 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) by Country
7.1.1 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country
7.1.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Market Facts & Figures by Type
7.3 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) by Region
8.1.1 Asia Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Region
8.1.2 Asia Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Facts & Figures by Type
8.3 Asia Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Facts & Figures by Application

9 Latin America
9.1 Latin America High Performance Active Pharmaceutical Ingredients (HPAPI) by Country
9.1.1 Latin America High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country
9.1.2 Latin America High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America High Performance Active Pharmaceutical Ingredients (HPAPI) Market Facts & Figures by Type
9.3 Central & South America High Performance Active Pharmaceutical Ingredients (HPAPI) Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa High Performance Active Pharmaceutical Ingredients (HPAPI) by Country
10.1.1 Middle East and Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country
10.1.2 Middle East and Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Market Facts & Figures by Type
10.3 Middle East and Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Market Facts & Figures by Application

11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description and Business Overview
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.1.5 Bristol-Myers Squibb Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.2.5 Novartis Related Developments
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Corporation Information
11.3.2 Sanofi Aventis Description and Business Overview
11.3.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.3.5 Sanofi Aventis Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.4.5 Pfizer Related Developments
11.5 Lonza
11.5.1 Lonza Corporation Information
11.5.2 Lonza Description and Business Overview
11.5.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.5.5 Lonza Related Developments
11.6 Novasep
11.6.1 Novasep Corporation Information
11.6.2 Novasep Description and Business Overview
11.6.3 Novasep Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.6.5 Novasep Related Developments
11.7 Hospira
11.7.1 Hospira Corporation Information
11.7.2 Hospira Description and Business Overview
11.7.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.7.5 Hospira Related Developments
11.8 BASF
11.8.1 BASF Corporation Information
11.8.2 BASF Description and Business Overview
11.8.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.8.4 BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.8.5 BASF Related Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Description and Business Overview
11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.9.5 Merck Related Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Description and Business Overview
11.10.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.10.5 Bayer Related Developments
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description and Business Overview
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
11.1.5 Bristol-Myers Squibb Related Developments
11.12 Boehringer Ingelheim
11.12.1 Boehringer Ingelheim Corporation Information
11.12.2 Boehringer Ingelheim Description and Business Overview
11.12.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Boehringer Ingelheim Products Offered
11.12.5 Boehringer Ingelheim Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Market Estimates and Projections by Region
12.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast by Regions 2021-2026
12.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast by Regions 2021-2026
12.2 North America High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast (2021-2026)
12.2.1 North America: High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast (2021-2026)
12.2.2 North America: High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast (2021-2026)
12.2.3 North America: High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast by Country (2021-2026)
12.3 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast (2021-2026)
12.3.1 Europe: High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast (2021-2026)
12.3.2 Europe: High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast (2021-2026)
12.3.3 Europe: High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast by Region (2021-2026)
12.5 Latin America High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast (2021-2026)
12.5.1 Latin America: High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast (2021-2026)
12.5.2 Latin America: High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast (2021-2026)
12.5.3 Latin America: High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key High Performance Active Pharmaceutical Ingredients (HPAPI) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Bristol-Myers Squibb、Novartis、Sanofi Aventis、Pfizer、Lonza、Novasep、Hospira、BASF、Merck、Bayer、Teva Pharmaceuticals、Boehringer Ingelheim

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の高性能医薬品有効成分(HPAPI)市場2026:インサイト・予測(Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。